Immunohistochemistry (IHC) is a powerful laboratory technique used to detect specific antigens in cells within tissue sections. By utilizing antibodies that bind to these antigens, IHC provides valuable information about the presence and distribution of proteins, helping in the identification and classification of diseases, particularly cancers.
Diagnostic Applications
IHC plays a crucial role in the diagnosis of cancer. By identifying specific tumor markers, our IHC services can differentiate between various types of cancer and subtypes, aiding in accurate diagnosis and personalized treatment plans. Common markers include:
Prognostic Applications
IHC not only assists in diagnosing cancer but also provides prognostic information. These markers help predict outcomes and guide treatment strategies. Key prognostic markers include:
Predictive Markers
Our IHC services include testing for predictive markers that help determine the likely response to specific therapies. This personalized approach ensures that patients receive the most effective treatments, minimizing unnecessary side effects and optimizing outcomes.
Director
Consultant
Consultant
Associate Consultant
Consultant
Principal Consultant
Associate Consultant